¿ì¿µ¼· ¸íÀÇ

ÀÚ½ÅÀÇ ÁúȯÀ» ÀÌÇØÇÒ ¼ö ÀÖ°Ô ÇÏ´Â Á¤½Å¾à¹°Ä¡·á Àü¹®°¡

¿ì¿µ¼· ¸íÀÇ

  • ¼Ò ¼Ó
    ¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø Á¤½Å°Ç°­ÀÇÇаú
  • Àü¹®ºÐ¾ß
    ¿ì¿ïÁõ, ¾ç±Ø¼ºÀå¾Ö(Á¶¿ïÁõ), ¼ºÀÎ ADHD, Á¤½Å¾à¹°ÇÐ

¿ì¿µ¼· ¿øÀåÀº °¡Å縯´ëÇб³ Á¤½Å°Ç°­ÀÇÇаú ±³¼ö·Î ÀçÁ÷ÇÏ¸ç ¾ç±Ø¼ºÀå¾Ö, ¿ì¿ïÀå¾Ö, ¼ºÀÎ ADHD, Á¤½Å¾à¹°Ä¡·á¿¡ ´ëÇÏ¿© dzºÎÇÑ ÀÓ»ó°æÇè°ú 200¿©ÆíÀÇ ³í¹®À» ¹ßÇ¥ÇÏ´Â ¿¬±¸¼º°ú¸¦ ½×¾Ò´Ù. ±×´Â °³¿ø ÈÄ¿¡´Â ȯÀÚÀÇ »î¿¡ ´ëÇÑ ÀÌÇØ¸¦ ¹ÙÅÁÀ¸·Î °úÇÐÀû ±Ù°Å¸¦ ÅëÇÕÇÏ´Â ÃÖÀûÀÇ ¾à¹°Ä¡·á¿Í ¸ÂÃãÇü °ü¸®¸¦ Á¦°øÇÏ´Â µî ȯÀÚÀÇ Æ¯¼º°ú Çʿ並 ¹Ý¿µÇÑ ÅëÇÕÀû Ä¡·á¸¦ ÅëÇØ Áõ»ó °³¼±°ú »îÀÇ Áú Çâ»óÀ» ¸ñÇ¥·Î Áø·áÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °¡Å縯´ëÇб³ Àǰú´ëÇÐ Çлç
  • °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¼®»ç
  • °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°­ÀÇÇаú ´ëÇ¥¿øÀå
  • °¡Å縯´ëÇб³ ¿©Àǵµ¼º¸ðº´¿ø Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó°úÀå(2022 ~ 2023)
  • °¡Å縯´ëÇб³ ¿©Àǵµ¼º¸ðº´¿ø ±³¼ö(2011 ~ 2024)
  • °¡Å縯´ëÇб³ ´ëÀü¼º¸ðº´¿ø ±³¼ö(2007 ~ 2011)

¼ö»ó³»¿ª

Awards List
  • ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ ¿ÀÃ÷Ä« Çмú»ó(2017)
  • ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çмú»ó(2016)
  • ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ ½ÅÁøÀÇÇÐÀÚ»ó(2013)
  • ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó(2011)
  • ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó(2009)

ÇÐȸȰµ¿

Academic activities
  • 2019 ~ 2023´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãѹ«ÀÌ»ç
  • 2002 ~ ÇöÀç´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¤È¸¿ø
  • 2016 ~ ÇöÀç´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãѹ«ÀÌ»ç
  • 2021 ~ ÇöÀç¾Æ½Ã¾Æ Á¤½Å¾à¹°ÇÐȸ ÀÌ»ç (Council Member of Asian College of Neuropsychopharmacology)
  • 2023 ~ ÇöÀç´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ ÇмúÀÌ»ç
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö Journal of Affective Disorder
Á¦ ¸ñ Prevalence and Comorbidities of Adult Attention-deficit/hyperactivity Disorder in a Community Sample from Korea
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Clinical Psychopharmacology and Neuroscience
Á¦ ¸ñ The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö PLoS One
Á¦ ¸ñ Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö International Journal of Molecular Science
Á¦ ¸ñ Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö PLoS One
Á¦ ¸ñ Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö Clinical Psychopharmacology and Neuroscience
Á¦ ¸ñ Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder
¹ßÇ¥³âµµ 2016 ¹ßÇ¥Áö International Clinical Psychopharmacology

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø

ÀÇ¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-6952-7571

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°­ÀÇÇаú´Â 20³â ÀÌ»ó ´ëÇк´¿ø¿¡¼­ ±³¼ö·Î ÀçÁ÷ÇÏ¸ç ¾ç±Ø¼ºÀå¾Ö, ¿ì¿ïÁõ, ¼ºÀÎ ADHD µî ´Ù¾çÇÑ Á¤½ÅÁúȯÀÇ ¾à¹°Ä¡·á¸¦ ¿¬±¸Çؿ Àü¹®°¡µéÀÌ ÇÔ²²ÇÏ´Â º´¿øÀ¸·Î, Á¤È®ÇÑ Áø´Ü°ú °úÇÐÀû ±Ù°Å ¹× ȯÀÚ °³ÀΠƯ¼º¿¡ ¹ÙÅÁÀ» µÐ Ä¡·á¸¦ ÅëÇØ ȯÀÚÀÇ »î°ú ¸¶À½À» Ä¡À¯ÇÕ´Ï´Ù.

¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¿µµîÆ÷±¸ 63·Î 36, ¸®¹öŸ¿ö 601È£

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä